ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

Funding opportunities listed.

April 30, 2004

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004